AAO: Medication could reduce burden of steroid drops for patients

Video

Cynthia Matossian, MD, FACS, ABES, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.


Cynthia Matossian, MD, FACES, ABES, of Matossian Eye Associates, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.

The study examined early experiences among cataract surgeons with the use of the injectabcle ophthalmic anti-inflammatory medications.Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.

Related Videos
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Colman Cawe, director of fundraising and communications, Orbis UK
Aleksandra Rachiskaya, MD, of the Cole Eye Institute at the Cleveland Clinic, Cleveland, Ohio, US, at ASRS 2023.
Related Content
A nurse helps a patient who uses a walker and glasses. Image credit: ©Dorde – stock.adobe.com

Collaborative rheumatologic–ophthalmologic teams could improve management of patients with rheumatic diseases

December 7th 2023
Article

Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management

Carbomer-containing gels from Aacarb, Aacomer and Puroptics could be at risk of contamination. Images courtesy of MHRA.

MHRA issues safety recall for dry eye gel treatments

November 28th 2023
Article

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

A researcher in personal protective equipment looks at a white rabbit in a glass tank. Image credit: ©Elnur – stock.adobe.com

Novel 3D-printed device may offer a new method to test pharmaceuticals

November 28th 2023
Article

Moving toward eliminating drug and chemical safety testing in animals

A person holds a phone in their hand. Above the phone, icons such as a cross, a pill, a wheelchair and a syringe indicate they are looking at health information. Image credit: ©Monster Ztudio – stock.adobe.com

Harnessing digital media for enhanced patient engagement and outcomes

November 27th 2023
Article

Patients who received digital education demonstrated a better understanding of their disease and its management

A photo of downtown London. Image credit: ©zgphotography – stock.adobe.com

MHRA issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI®)

November 13th 2023
Article

The company received marketing authorisation approval in the EU earlier this year

AAO 2023: Advancements in dry age-related macular degeneration treatment

AAO 2023: Advancements in dry age-related macular degeneration treatment

November 6th 2023
Article

Peter K. Kaiser, MD, provides an overview of innovative therapies in development for patients with dry age-related macular degeneration.

© 2023 MJH Life Sciences

All rights reserved.